South Africa halts Astrazeneca vaccine push over effectiveness fears
Published
A study has suggested that the vaccine is only 22% effective against moderate forms of the virus.
Full ArticlePublished
A study has suggested that the vaccine is only 22% effective against moderate forms of the virus.
Full ArticleIt began as a shudder through the scientific and public health establishments. A new variant of the novel coronavirus SARS-CoV-2..
New results from a COVID-19 vaccine trial in South Africa suggest the vaccine that was developed by AstraZeneca may not be as..